K
Kathleen Bennett
Researcher at Royal College of Surgeons in Ireland
Publications - 396
Citations - 11531
Kathleen Bennett is an academic researcher from Royal College of Surgeons in Ireland. The author has contributed to research in topics: Population & Mortality rate. The author has an hindex of 50, co-authored 380 publications receiving 9812 citations. Previous affiliations of Kathleen Bennett include Johns Hopkins University & Mercer University.
Papers
More filters
Journal ArticleDOI
Beta Blockers and Breast Cancer Mortality: A Population- Based Study
Thomas I. Barron,Roisin M. Connolly,Roisin M. Connolly,Linda Sharp,Linda Sharp,Kathleen Bennett,Kathleen Bennett,Kala Visvanathan +7 more
TL;DR: Evidence in humans is provided to support preclinical observations suggesting that inhibiting the β₂-adrenergic signaling pathway can reduce breast cancer progression and mortality.
Journal ArticleDOI
Potentially inappropriate prescribing and cost outcomes for older people: a national population study
TL;DR: A retrospective national population study on the prevalence of potentially inappropriate prescribing in a national Irish older population using European specific explicit prescribing criteria identifies a high prevalence of PIP in Ireland with significant cost consequences.
Journal ArticleDOI
Anticholinergic drugs and risk of dementia : case-control study
Kathryn Richardson,Chris Fox,Ian Maidment,Nicholas Steel,Yoon K. Loke,Antony Arthur,Phyo K. Myint,Carlota M. Grossi,Katharina Mattishent,Kathleen Bennett,Noll L. Campbell,Malaz Boustani,Louise Robinson,Carol Brayne,Fiona E. Matthews,George M. Savva +15 more
TL;DR: A robust association between some classes of anticholinergic drugs and future dementia incidence was observed, and this could be caused by a class specific effect, or by drugs being used for very early symptoms of dementia.
Journal ArticleDOI
Early discontinuation of tamoxifen: a lesson for oncologists.
TL;DR: The purpose of the study was to assess rates of tamoxifen nonpersistence (early discontinuation) in women aged 35 years or older using prescription refill data from a national prescribing database.
Journal ArticleDOI
Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002.
TL;DR: More than half of the substantial CHD mortality decrease in Sweden between 1986 and 2002 was attributable to reductions in major risk factors, mainly a large decrease in total serum cholesterol.